Thrivent Financial For Lutherans Novo Nordisk A S Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Novo Nordisk A S stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 129,600 shares of NVO stock, worth $11.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

129,600

Previous 790,425 83.6%

Holding current value

$11.3 Million

Previous $113 Million 86.32%

% of portfolio

0.03%

Previous 0.23%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$119.07 - $145.42 $78.7 Million - $96.1 Million	-660,825 Reduced 83.6%	129,600 $15.4 Million
Q2 2024 Aug 13, 2024	SELL	$122.71 - $146.91 $66.9 Million - $80.1 Million	-545,344 Reduced 40.83%	790,425 $113 Million
Q1 2024 May 14, 2024	SELL	$102.11 - $135.92 $6.91 Million - $9.19 Million	-67,624 Reduced 4.82%	1,335,769 $172 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $31.6 Million - $37.9 Million	359,798 Added 34.48%	1,403,393 $145 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $68 Million - $149 Million	747,696 Added 252.69%	1,043,595 $94.9 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $1.21 Million - $1.33 Million	7,729 Added 2.68%	295,899 $47.9 Million
Q1 2023 May 17, 2023	SELL	$132.34 - $159.14 $30.5 Million - $36.7 Million	-230,645 Reduced 44.46%	288,170 $45.9 Million
Q4 2022 Feb 08, 2023	SELL	$102.55 - $135.33 $26 Million - $34.4 Million	-253,871 Reduced 32.86%	518,815 $70.2 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $6.36 Million - $7.81 Million	66,786 Added 9.46%	772,686 $77 Million
Q2 2022 Aug 16, 2022	SELL	$103.24 - $121.81 $15 Million - $17.7 Million	-145,696 Reduced 17.11%	705,900 $78.7 Million
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $2.8 Million - $3.38 Million	30,026 Added 3.65%	851,596 $94.6 Million
Q4 2021 Feb 16, 2022	BUY	$95.88 - $117.08 $14.4 Million - $17.5 Million	149,897 Added 22.32%	821,570 $92 Million
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $19.2 Million - $24.2 Million	-227,084 Reduced 25.27%	671,673 $64.5 Million
Q2 2021 Aug 19, 2021	BUY	$67.66 - $84.76 $2.64 Million - $3.31 Million	39,038 Added 4.54%	898,757 $75.3 Million
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $4.47 Million - $5.06 Million	66,701 Added 8.41%	859,719 $58 Million
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $3.9 Million - $4.51 Million	61,068 Added 8.34%	793,018 $55.4 Million
Q3 2020 Nov 10, 2020	BUY	$63.69 - $70.22 $407,998 - $449,829	6,406 Added 0.88%	731,950 $50.8 Million
Q2 2020 Aug 12, 2020	BUY	$58.54 - $67.94 $42.5 Million - $49.3 Million	725,544 New	725,544 $47.5 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Novo Nordisk A S Transaction History